Session 3: Biomarkers and prognostic profiling

Back

Session 3: Biomarkers and prognostic profiling

Lessons from molecular subtyping:
Carlos Caldas

Clinical utility of molecular profiles:
Dr Rob Stein

Identifying who needs extended adjuvant ET:
Dr Dan Hayes

Mutation-directed therapy:
Dr Fabrice Andre